US 12,310,945 B2
Cyclohexylglycine derivatives as selective cytotoxic agents
Douglas C. Beshore, Lower Gwynedd, PA (US); Keith P. Moore, Doylestown, PA (US); Rajan Anand, Orinda, CA (US); Remond Moningka, Jersey City, NJ (US); and William D. Shipe, Chalfont, PA (US)
Assigned to Merck Sharp & Dohme LLC, Rahway, NJ (US)
Filed by Merck Sharp & Dohme LLC, Rahway, NJ (US)
Filed on Dec. 22, 2022, as Appl. No. 18/145,127.
Prior Publication US 2024/0252466 A1, Aug. 1, 2024
Int. Cl. A61K 31/4035 (2006.01); A61K 45/06 (2006.01); A61P 31/18 (2006.01)
CPC A61K 31/4035 (2013.01) [A61K 45/06 (2013.01); A61P 31/18 (2018.01)] 10 Claims
 
1. A compound that is

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.